Rhoen Klinikum (RHK) PT Set at €25.50 by Warburg Research

Rhoen Klinikum (ETR:RHK) has been given a €25.50 ($29.65) target price by analysts at Warburg Research in a research report issued on Friday, Borsen Zeitung reports. The firm currently has a “neutral” rating on the stock. Warburg Research’s target price indicates a potential downside of 4.67% from the stock’s current price.

Other analysts also recently issued research reports about the stock. Kepler Capital Markets set a €19.00 ($22.09) price target on shares of Rhoen Klinikum and gave the company a “sell” rating in a research report on Thursday, April 11th. Berenberg Bank set a €23.50 ($27.33) price target on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research report on Thursday, April 11th. Credit Suisse Group set a €17.00 ($19.77) price target on shares of Rhoen Klinikum and gave the company a “sell” rating in a research report on Wednesday, January 23rd. Finally, Independent Research set a €26.00 ($30.23) price target on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research report on Monday, April 1st. Four investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. The stock presently has a consensus rating of “Sell” and a consensus price target of €22.10 ($25.70).

Shares of RHK stock traded up €0.15 ($0.17) during trading hours on Friday, hitting €26.75 ($31.10). 32,269 shares of the company were exchanged, compared to its average volume of 43,281. The company has a market cap of $1.79 billion and a price-to-earnings ratio of 36.64. Rhoen Klinikum has a fifty-two week low of €21.06 ($24.49) and a fifty-two week high of €28.30 ($32.91). The company has a quick ratio of 1.53, a current ratio of 1.76 and a debt-to-equity ratio of 9.10.

About Rhoen Klinikum

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Read More: What is a short straddle?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.